Your browser does not support JavaScript or it may be disabled!

NewsApp (Free)

Read news as it happens
Download NewsApp
rediff.com
 India As It Happens
Rediff Labs will showcase innovative products that rediff is working on behind the scenes.
News Home   |   Images Home
 rediff News App

About 332 results for "amgen rank"

The Zacks Analyst Blog Highlights: Genomic Health, Sanofi, Reg...

Zacks.com announces the list of stocks featured in the Analyst Blog. Every day the Zacks Equity Research analysts discuss the latest news and events impacting stocks and the financial markets. Stocks recently featured in the blog include Genomic ... Yahoo! Finance, 4 days ago
[x]  
(3) images for "amgen rank"
Forbes.com, 2 months ago
Forbes.com, 2 months ago
Forbes.com, 3 months ago
Los Angeles Times

BRIEF: Amgen Tour of California starts Sunday in Escondido

The eighth Amgen Tour of California begins at 11:15 a.m. Sunday in Escondido, and for the first time the largest cycling stage race in the United States is traveling from south to north. The 750-mile trip will end May 19 in Santa Rosa. Matt ...
 Individual.com1 week ago Amgen Tour of California starts Sunday in Escondido  Los Angeles Times1 week ago 2013 Amgen Tour of California will race from South to North  India Infoline1 month ago Escondido to Host Official 2013 Amgen Tour of California Cha. . .  Equities.com1 month ago
Seeking Alpha

Amgen To Set Up JV In China

Amgen to Set Up JV in China - By Zacks Investment Research Amgen ( AMGN ) recently announced its intention to set up a joint venture (JV) in China with Zhejiang Beta Pharma Co., Ltd. The JV will focus on the commercialization of Amgen's colorectal ...
 Seeking Alpha12 hours ago Amgen to Set Up JV in China Zacks  Yahoo! Finance5 days ago Amgen to Set Up JV in China - Analyst Blog  Nasdaq5 days ago
[x]  

Q1 Revenue In-Line. Amgen Deal Is Encouraging Zacks

By Brian Marckx, CFAQ1 2013 RESULTS: Revenue In-Line, EPS Miss on Higher SG&A. Amgen Deal is Encouraging… Transgenomic (OTC:TBIO) reported financial results for Q1 ending March 31, 2013 on May 8th. Revenue was up 2% yoy and dead-on with our $7.4 ...
 Yahoo! Finance1 week ago Positive Data on Amgen Candidate - Analyst Blog  Zacks.com1 month ago Positive Data on Amgen Candidate - Analyst Blog  Quote.com India1 month ago

Tax Benefit Boosts Amgen Earnings Zacks

Amgen (AMGN) reported first quarter 2013 earnings of $1.95 per share, 20 cents above the Zacks Consensus Estimate and 22.6% above the year-ago earnings. Tax benefits and a lower share count contributed to the year-over-year increase in earnings. The ...
 Yahoo! Finance3 weeks ago Tax Benefit Boosts Amgen Earnings - Analyst Blog  Nasdaq3 weeks ago Tax Benefit Boosts Amgen Earnings - Analyst Blog  Quote.com India3 weeks ago

Should You Buy Stock in Amgen After the Q1 Results Pullback?

Keep track of the stocks that matter to you. Help yourself with the Fool's FREE and easy new watchlist service today. When it comes to biotechs, Amgen (NASDAQ: AMGN ) qualifies for the senior citizen discount. The company, founded way back in 1980, ...
 Motley Fool3 weeks ago

Will Amgen Beat Earnings? - Analyst Blog

We expect Amgen Inc. ( AMGN ) to beat earnings expectations when it reports first-quarter 2013 results after the closing bell on Apr 23, 2013. Why a Likely Positive Surprise? Our proven model shows that Amgen has the right combination of two ...
 Zacks.com3 weeks ago Will Amgen Beat Earnings? Zacks  Yahoo! Finance3 weeks ago
[x]  

Santa Rosa Hosts Finish of 2013 Amgen Tour of California and Makes History

In an unprecedented event the city of Santa Rosa, located in the heart of Northern California's Sonoma Wine Country will host the overall finish of the world wide prestigious Amgen Tour of California. The quaint town known as one of the top cycling ...
 Broadway World1 month ago Santa Rosa Makes History as First Northern California City to Host Finish of 2013 Amgen Tour of California  Individual.com1 month ago

Patent loss pushes Lipitor to 17th rank in 2012, Abbott's Humira is world's largest selling drug

The most significant development in the global pharmaceutical market in 2012 is the displacement of Lipitor of Pfizer from its number one pharmaceutical product by Humira of Abbott. Lipitor, the cholesterol drug of Pfizer has been the top ...
 PharmaBiz1 month ago

Shares of Biogen Idec Rank the Highest in Terms of Free Cash Flow Per Share in the Biotechnology Industry (BIIB, AMGN, CELG, UTHR, ALXN)

(SmarTrend(R) News Watch via COMTEX) -- Below are the three companies in the Biotechnology industry with the highest free cash flow per share. FCF/share is a valuable metric signaling a company's ability to facilitate growth in the business.Biogen ...
 TMC Net1 month ago Relatively High Free Cash Flow Per Share Detected in Shares of Biogen Idec in the Biotechnology Industry (BIIB, AMGN, CELG, UTHR, ALXN)  TMC Net1 week ago
Prev | Next
Personalize your Realtimeclose [x]
Add content to your personalized tab - My News
Add upto 6 topics of your interest:
for eg.2g Scam , World
1.
2.
3.
4.
5.
6.
Personalize the tabs display. ( You can add or remove the tabs )
AlertsGet updates on latest news & your favourite topics right in your inbox.Set an Alert|Manage your Alerts
WidgetGet Realtime news on your homepage & get your members hooked.Add Realtime Widget
 rediff News App

Get

Realtime News

on your Webpage

Add Widget >Get your members hooked!
    
Alerts
Get updated on latest news & your favorite topics right in your inbox!
    
Widget
Get Realtime News on your webpage & get your members hooked!
 
More     Less